Trauma and Orthopaedic Department, St George's Hospital, St George's University of London, London, UK.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Bone Joint J. 2019 Jun;101-B(6):639-645. doi: 10.1302/0301-620X.101B6.BJJ-2018-1421.R1.
The Ponseti method is the benchmark treatment for the correction of clubfoot. The primary rate of correction is very high, but outcome further down the treatment pathway is less predictable. Several methods of assessing severity at presentation have been reported. Classification later in the course of treatment is more challenging. This systematic review considers the outcome of the Ponseti method in terms of relapse and determines how clubfoot is assessed at presentation, correction, and relapse.
A prospectively registered systematic review was carried out according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Studies that reported idiopathic clubfoot treated by the Ponseti method between 1 January 2012 and 31 May 2017 were included. The data extracted included demographics, Ponseti methodology, assessment methods, and rates of relapse and surgery.
A total of 84 studies were included (7335 patients, 10 535 clubfeet). The relapse rate varied between 1.9% and 45%. The rates of relapse and major surgery (1.4% to 53.3%) and minor surgery (0.6% to 48.8%) both increased with follow-up time. There was high variability in the assessment methods used across timepoints; only 57% of the studies defined relapse. Pirani scoring was the method most often used.
Recurrence and further surgical intervention in idiopathic clubfoot increases with the duration of follow-up. The corrected and the relapsed foot are poorly defined, which contributes to variability in outcome. The results suggest that a consensus for a definition of relapse is needed. Cite this article: 2019;101-B:639-645.
潘塞提方法是治疗马蹄足的基准疗法。初始矫正率非常高,但治疗过程中后续的结果则更难以预测。目前已经报道了几种用于评估初始严重程度的方法。在治疗过程中更晚的时间进行分类则更具挑战性。本系统评价根据复发情况来评估潘塞提方法的结果,并确定在初始、矫正和复发时如何评估马蹄足。
根据系统评价和荟萃分析的首选报告项目(PRISMA)指南,进行了前瞻性系统评价。纳入的研究报告了 2012 年 1 月 1 日至 2017 年 5 月 31 日期间采用潘塞提方法治疗的特发性马蹄足。提取的数据包括人口统计学资料、潘塞提方法、评估方法以及复发和手术的发生率。
共纳入 84 项研究(7335 例患者,10535 只足)。复发率在 1.9%至 45%之间。复发率和主要手术(1.4%至 53.3%)以及次要手术(0.6%至 48.8%)均随随访时间的延长而增加。在不同时间点使用的评估方法存在高度变异性;只有 57%的研究定义了复发。皮拉尼评分是最常使用的方法。
特发性马蹄足的复发和进一步的手术干预随随访时间的延长而增加。矫正足和复发足的定义不明确,这导致结果存在差异。结果表明,需要就复发的定义达成共识。
2019;101-B:639-645.